Pages that link to "Q46629936"
Jump to navigation
Jump to search
The following pages link to Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B. (Q46629936):
Displaying 42 items.
- KASL clinical practice guidelines: management of chronic hepatitis B (Q26752475) (← links)
- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection (Q29615868) (← links)
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. (Q30391932) (← links)
- A Systematic Review of Side Effects of Nucleoside and Nucleotide Drugs Used for Treatment of Chronic Hepatitis B. (Q33819098) (← links)
- Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the (Q34212799) (← links)
- Phase I, open-label, single-dose study to evaluate the pharmacokinetics and safety of telbivudine in children and adolescents with chronic hepatitis B. (Q34775178) (← links)
- Association between adefovir dipivoxil treatment and the risk of renal insufficiency in patients with chronic hepatitis B: A meta-analysis (Q35180009) (← links)
- Factors Predicting the Effi cacy of Adefovir Dipivoxil on Treatment-Naïve Chronic Hepatitis B Patients at 48 Weeks (Q35619167) (← links)
- Antiviral therapy in management of chronic hepatitis B viral infection in children: A systematic review and meta-analysis (Q35840956) (← links)
- Nephrotoxicity caused by oral antiviral agents in patients with chronic hepatitis B treated in a hospital for tropical diseases in Thailand (Q35864595) (← links)
- KASL Clinical Practice Guidelines: Management of chronic hepatitis B. (Q36153966) (← links)
- Vitamin E for the treatment of children with hepatitis B e antigen-positive chronic hepatitis: A systematic review and meta-analysis (Q36308020) (← links)
- HIV/HBV coinfection in children and antiviral therapy (Q36775147) (← links)
- Hepatitis B therapy in children (Q37390647) (← links)
- Special populations with hepatitis B virus infection (Q37462584) (← links)
- SASLT practice guidelines for the management of hepatitis B virus. (Q37634822) (← links)
- Pediatric hepatitis B treatment (Q37666967) (← links)
- Treatment of viral hepatitis B in children (Q37702241) (← links)
- Treatment of children with chronic hepatitis B virus infection in the United States: Patient selection and therapeutic options (Q37796726) (← links)
- Antiviral therapy for hepatitis B in special populations (Q37819694) (← links)
- Treatment of special populations with chronic hepatitis B infection (Q37886158) (← links)
- Drug safety evaluation of adefovir in HBV infection (Q37889298) (← links)
- Medical management of chronic liver diseases in children (part I): focus on curable or potentially curable diseases (Q37945752) (← links)
- Adefovir dipivoxil in chronic hepatitis B: history and current uses (Q37975548) (← links)
- Chronic hepatitis B in children and adolescents (Q38013464) (← links)
- Treatment of children with chronic viral hepatitis: what is available and what is in store (Q38127616) (← links)
- Management of chronic hepatitis B infection (Q38210526) (← links)
- Management of chronic hepatitis B in children: an unresolved issue (Q38215076) (← links)
- Liquid oral suspension adefovir dipivoxil (GS-02-526): an update on treatments for hepatitis B infection (Q38220090) (← links)
- Hepatitis B virus infection in children (Q38365905) (← links)
- Lamivudine resistance in children with chronic hepatitis B. (Q38456918) (← links)
- Rethinking the pathogenesis of hepatitis B virus (HBV) infection (Q38491309) (← links)
- Chronic hepatitis B in children: Therapeutic challenges and perspectives. (Q38854648) (← links)
- Hepatitis B and C. (Q39305112) (← links)
- Does genotype predict response to treatment in children infected with hepatitis B perinatally? (Q39561843) (← links)
- Randomized, controlled trial of entecavir versus placebo in children with hepatitis B envelope antigen-positive chronic hepatitis B. (Q41533462) (← links)
- Characterization of the dynamics of hepatitis B virus resistance to adefovir by ultra-deep pyrosequencing. (Q44675493) (← links)
- De novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation (Q45333184) (← links)
- A Multicenter Study of the Antiviral Efficacy of Entecavir Monotherapy Compared to Lamivudine Monotherapy in Children with Nucleos(t)ide-naïve Chronic Hepatitis B. (Q50019524) (← links)
- INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Corticosteroids (Q90648680) (← links)
- Hepatitis B virus infection in children and adolescents (Q93080857) (← links)
- Hepatitis B virus infection in children (Q93140478) (← links)